Global

‡ In these countries please contact our distributor

RENASYS GO

This information is intended for HCPs in the US.
Please consult your local Smith + Nephew representative for further details on products available in your market. 

 

Powerful, portable NPWT

Convenient and clinically effective NPWT for post-acute care1 

The RENASYS GO System provides powerful NPWT to support the management of complex wounds for ambulatory or post-acute patients. In applying controlled levels of sub-atmospheric pressure,2 it works to effectively manage wounds in a variety of ways.1 

RENASYS GO tNPWT is sleek, quiet, and lightweight to gives patients the care, confidence, and mobility they need to get better…and get back to their lives.

Simple, flexible, portable

Combining clinical efficacy1 with comfort, convenience, and mobility, the RENASYS GO System provides versatility for a wide range of wounds in post-acute settings.1,3,4

Simplicity

  • Intuitive interface – easy to use for providers and patients
  • Safety alerts – low pressure, high vacuum, blockages, canister full, and low battery
  • Home health mode – locks buttons to protect therapy settings
  • Disposable canisters and easy cleaning – for sanitary operation
  • Compatible with RENASYS TOUCH tNPWT – a shared consumables range allows for a seamless transition from acute to post-acute care

Flexibility

  • For a wide variety of wound types and care settings – easing the transition from acute to outpatient, home care or long-term care
  • Various digital pressure settings – for personalized therapy
  • Continuous and intermittent modes – to help tailor individualized therapy
  • Unique Soft Port – provides a soft, cushioned channel for greater patient comfort during therapy5

Portability

  • Compact and lightweight – only 2.4lbs, for greater patient mobility
  • Sleek and quiet – to enhance patient experience
  • 20-hour battery life – charges and operates while plugged in
  • Customized carrying – features a discreet black case with adjustable strap

How to use RENASYS GO tNPWT

Watch: Usage and functionality

For additional guidance, please refer to the clincal resources page.

Coming through with real results

A study comparing RENASYS GO tNPWT to the V.A.C.™ range found no statistical difference in achieving significant treatment milestones. *3

Conclusion: RENASYS GO tNPWT is an efficient and cost-effective alternative NPWT system for managing various wound types.3

Suitable for a wide range of wound types

OneNPWT portfolio – simple just got simpler

One compelling solution to meet your negative pressure wound therapy needs at every stage of the wound care journey.6-12 

For additional guidance on product selection, visit OneNPWT

Ordering information and support

For further information and guidance, please contact us

For ordering information (RENASYS GO), contact your local Rotech® Healthcare Inc sales representative

For system availability (RENASYS GO), consult the WoundExpert® electronic health records

Helping you get CLOSER TO ZERO  delay in wound healing.1

Important Safety Information

The information herein is intended for healthcare professionals. RENASYS is contraindicated in the presence of untreated osteomyelitis, exposed arteries/veins/organs/nerves, necrotic tissue with eschar present, malignancy in the wound, non-enteric and unexplored fistulas, and exposed anastomotic sites. Excessive bleeding is a serious risk associated with the application of suction to wounds, which may result in death or serious injury. For full product and safety information, please see the Instructions for Use.

*n=42

All trademarks acknowledged.

References:
1.    Hurd T, Rossington A, Trueman P, Smith J. A Retrospective Comparison of the Performance of Two Negative Pressure Wound Therapy Systems in the Management of Wounds of Mixed Etiology. Advances in Wound Care. 2017;6(1):33-37.
2.    Apelqvist J, Willy, C.,Fagerdahl, a, Malmsjoe, M., Plaggesi, A., Probst, A., and Vowden, P., . EWMA Document: Negative Pressure Wound Therapy Overview, Challenges Perspectives. Journal of Wound Care. 2017;26(3):S1-S154.
3.    Rahmanian-Schwarz A, Willkomm LM, Gonser P, Hirt B, Schaller HE. A novel option in negative pressure wound therapy (NPWT) for chronic and acute wound care. Burns. 2012;38(4):573-577.
4.    IECEE 2016.IEC SYSTEM FOR MUTUAL RECOGNITION OF TEST CERTIFICATES FOR ELECTRICAL EQUIPMENT (IECEE) CB SCHEME. US/6298/ITS.
5.    Carnali M, Ronchi R, FinocchiL, Spuri Capesciotti S, Paggi B. Retrospective study on the use of negative pressure wound therapy in the treatment of pilonidal cysts (sinus pilonidalis) operated on using an open technique or complicated by dehiscence of the surgery site through sepsis. Acta Vulnologica. 2016;14(1):24-39.
6.    Forlee M, Richardson J, Rossington A, Cockwill J, Smith J. An interim analysis of device functionality and usability of RENASYS™ TOUCH – a new portable Negative Pressure Wound Therapy (NPWT) system. Paper presented at: Wounds UK; 2016; Harrogate, UK.
7.    Smith & Nephew January 2018. Outcomes following PICO compared to conventional dressings when used prophylactically on closed surgical incisions: systematic literature review and meta-analysis. Internal Report. EO/AWM/PICO/004/v1
8.    Hurd T, Chadwick P, Cote J, et al. Impact of gauze-based NPWT on the patient and nursing experience in the treatment of challenging wounds. International Wound Journal. 2010;7(6):448-455.
9.    Kantar Health market research report, November 2018.
10.    O’leary DP, Peirce C, Anglim B, et al.Prophylactic Negative Pressure Dressing Use in Closed Laparotomy Wounds Following Abdominal Operations: A Randomized, Controlled, Open-label Trial: The P.I.C.O. Trial. Ann Surg. 2017;265(6):1082-1086.
11.    Selvaggi F, Pellino G, Sciaudone G, et al.New Advances in Negative Pressure Wound Therapy (NPWT) for Surgical Wounds of Patients Affected with Crohn’s Disease. Surgical Technology International. 2014;24:83-89.
12.    Karlakki SL, Hamad AK, Whittall C, et al.Incisional negative pressure wound therapy dressings (iNPWTd) in routine primary hip and knee arthroplasties: A randomised controlled trial. Bone Joint Res. 2016;5(8):328-337.
13.    Dowsett C, et al. Use of PICO to improve clinical and economic outcomes in hard-to-heal wounds. Wounds International. 2017;8, p53–58.
14.    Kirsner R, Dove C, Reyzelman A, Vayser D, Jaimes H. A prospective, randomized, controlled clinical trial on the efficacy of a single-use negative pressure wound therapy system, compared to traditional negative pressure wound therapy in the treatment of chronic ulcers of the lower extremities. Wound Repair Regen. 2019 Sept;27(5):519-529.
Important Safety Information

 

The information herein is intended for healthcare professionals. RENASYS is contraindicated in the presence of untreated osteomyelitis, exposed arteries/veins/organs/nerves, necrotic tissue with eschar present, malignancy in the wound, non-enteric and unexplored fistulas, and exposed anastomotic sites. Excessive bleeding is a serious risk associated with the application of suction to wounds, which may result in death or serious injury. For full product and safety information, please see the Instructions for Use.

How does RENASYS compare to V.A.C.™?

Find out more

RENASYS◊  GO
Post-Acute NPWT Solution in the United States

Order your RENASYS GO pump in the US through Rotech Healthcare, Inc.

Download now

Intended for HCPs in the US only